Zydus Lifesciences, a leading global healthcare company, has solidified its presence in the US market through a strategic partnership with Viwit Pharmaceuticals. The agreement grants Zydus exclusive rights to market, distribute, and sell generic versions of GADAVIST™ (gadobutrol injection) and DOTAREM® (gadoterate meglumine injection) in the United States. Viwit will be responsible for the development, …


